Jared Wheat (Tag Archives)
Subscribe to PricePlow's Newsletter and Jared Wheat Alerts
DMAA Banned From Supplements: Hi-Tech Pharmaceuticals Loses Appeal
Update April 17, 2020: Hi-Tech Pharma’s request for an En Banc Review (filed October 15, 2019) has been denied. See the Judge’s final response here.
This effectively ends the Hi-Tech DMAA Lawsuit, unless they were to somehow take this to the Supreme Court, which seems unlikely given the current political climate.
On August […]
Continue Reading →
Government Ordered to Return Five Truckloads of DMAA to Hi-Tech Pharma
All has been quiet on the DMAA front, pending Hi-Tech’s DMAA Lawsuit Appeal to the 11th Circuit, a decision we’re still waiting on after oral arguments were heard in August 2018.
We finally have a bit of an update, but it’s important to stress that Hi-Tech is still under an order from Judge Alan Braverman […]
Continue Reading →
DMAA FDA Lawsuit Appeal Oral Arguments: Hi-Tech Gets Their Day in Court
In March of 2018, we were left with Hi-Tech Pharmaceuticals’ appeal to the Eleventh Circuit court over their DMAA lawsuit against the FDA. Before we get into the update, a quick recap:
Hi-Tech appealed the ruling of district court judge Willis B. Hunt because he made his decision against them based upon information that neither[…]
Continue Reading →
FDA May Have to Return $3 MILLION Seized from Hi-Tech Pharma
It’s been a while since we’ve given an update on the ongoing series of legal battles between Hi-Tech Pharmaceuticals and the United States Federal Government, but we’re in the midst of one of the major decisions to come down over the past six months.
Where are we now?As a recap, there are a few […]
Continue Reading →
Hi-Tech’s FDA DMAA Lawsuit Recap (Updated April 2020)
Update April 17, 2020: Hi-Tech Pharma’s request for an En Banc Review (filed October 15, 2019) has been denied. See the Judge’s final response here.
This effectively ends the Hi-Tech DMAA Lawsuit, unless they were to somehow take this to the Supreme Court, which seems unlikely given the current political climate.
BREAKING (August […]
Continue Reading →
The Supplement Industry 2017 Year in Review: The 10 Biggest Stories
2017 was one to remember. It was filled with incredible highs and lows that make it one of the most tumultuous years in recent memory. As 2018 dawns, we take a look back at the previous 365 days to recount some of the most notable headlines that caught everyone’s attention.
A year like no other[…]Continue Reading →
Hi-Tech Fights to Get its Confiscated DMAA Back (December 2017)
Update May 3, 2019: A judge ordered the US Government to return Hi-Tech’s seized DMAA (see “Government Ordered to Return Five Truckloads of DMAA to Hi-Tech Pharma“), but it was ultimately for naught since Hi-Tech Lost the DMAA case.
Update December 28, 2017: Hi-Tech Pharmaceuticals has appealed the Magistrate Judge’s decision denying their request to […]
Continue Reading →
Aaron Singerman Interview: Business, Supplements, and FOCUS | Episode #003
On November 6, 2016, I had the honor to interview Aaron Singerman, the successful businessman, husband, and father who owns Redcon1 and half of Prime Nutrition.
Our conversation ranged from Redcon1 updates to supplements to entrepreneurship, as well as the current state of Aaron’s relationship with PJ Braun of Blackstone Labs.
It’s […]
Continue Reading →
Hi-Tech Pharmaceuticals Raided… Over RED YEAST RICE??
November 15, 2017 Update: Hi-Tech has filed a motion to amend the terms agreed to in this indictment (ie. they’re fighting […]
Continue Reading →
The Daniel Armstrong / Ying Zhang DMAA Study Scandal at University of Texas Arlington
This is part three of a six page series researching whether DMAA (1,3 dimethylamylamine) is a natural constituent of geranium flowers. All six parts are linked from our main DMAA in Nature / Geranium page.
In our previous article, we showed how paid researchers found DMAA but claimed that there was an “absense” of […]
Continue Reading →
